Collectively , findings suggest that yogic practice s may promote significant improvements in several indices of importance in DM2 management , including glycemic control , lipid levels , and body composition .
More limited data suggest that yoga may also lower oxidative stress and blood pressure ; enhance pulmonary and autonomic function , mood , sleep , and quality of life ; and reduce medication use in adults with DM2 .
A growing body of evidence suggests yogic practice s may benefit adults with type 2 diabetes ( DM2 ) .
In this systematic review , we evaluate available evidence from prospect i ve controlled trials regarding the effects of yoga-based programs on specific health outcomes pertinent to DM2 management .
Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study.
OBJECTIVE To examine prospect ively the relationship between diabetes , glycemic control , and spirometric measures . RESEARCH DESIGN AND METHODS From a community-based cohort , 495 Europid ( i.e. , of European descent ) patients with type 2 diabetes who had no history of pulmonary disease underwent baseline spirometry between 1993 and 1994 . A subset of 125 patients was restudied a mean of 7.0 years later . The main outcome measures included forced vital capacity ( FVC ) , forced expiratory volume in 1 s ( FEV1 ) , vital capacity ( VC ) , and peak expiratory flow ( PEF ) corrected for body temperature , air pressure , and water saturation and were expressed either in absolute terms or as percentage-predicted value for age , sex , and height . RESULTS Mean percentage-predicted values of each spirometric measure were decreased > 10 % in the whole cohort at baseline and absolute measures continued to decline at an annual rate of 68 , 71 , and 84 ml/year and 17 l/min for FVC , FEV1 , VC , and PEF , respectively , in the 125 prospect ively studied patients . Declining lung function measures were consistently predicted by poor glycemic control in the form of a higher up date d mean HbA1c , follow-up HbA1c , or follow-up fasting plasma glucose . In a Cox proportional hazards model , decreased FEV1 percentage-predicted value was an independent predictor of all-cause mortality . CONCLUSIONS Reduced lung volumes and airflow limitation are likely to be chronic complications of type 2 diabetes , the severity of which relates to glycemic exposure . Airflow limitation is a predictor of death in type 2 diabetes after adjusting for other recognized risk factors
Collectively , findings suggest that yogic practice s may promote significant improvements in several indices of importance in DM2 management , including glycemic control , lipid levels , and body composition .
More limited data suggest that yoga may also lower oxidative stress and blood pressure ; enhance pulmonary and autonomic function , mood , sleep , and quality of life ; and reduce medication use in adults with DM2 .
A growing body of evidence suggests yogic practice s may benefit adults with type 2 diabetes ( DM2 ) .
In this systematic review , we evaluate available evidence from prospect i ve controlled trials regarding the effects of yoga-based programs on specific health outcomes pertinent to DM2 management .